Skip to main content
. 2023 Jun 27;27:252. doi: 10.1186/s13054-023-04534-2

Table 1.

Characteristics of OHCA patients who underwent ECPR for medical causes

All (n = 1660) WLST (n = 510) no WLST (n = 1150) p-value
Baseline characteristics
Male gender, n (%) 1382/1660 (83.2) 427/510 (83.7) 965/1150 (83.9) 0.279
Age, median [IQR] 61 [50–69] 62 [51–70] 61 [49–68] 0.032
Cardiac arrest location 0.079
 Home, n (%) 674/1660 (40.6) 226/510 (44.3) 448/1150 (38.9)
 Public, n (%) 693/1660 (41.7) 193/510 (37.8) 500/1150 (43.4)
 Other, n (%) 293/1660 (17.6) 91/510 (17.8) 202/1150 (17.5)
PS before admission 0.107
 PS 0, n (%) 1462/1621 (90.1) 441/494 (89.2) 1021/1127 (90.5)
 PS 1, n (%) 127/1621 (7.8) 37/494 (7.4) 90/1127 (7.9)
 PS 2, n (%) 21/1621 (1.3) 11/494 (2.2) 10/1127 (0.8)
 PS 3, n (%) 11/1621 (0.6) 5/494 (1.0) 6/1127 (0.5)
 PS 4, n (%) 0/1621 (0) 0/494 (0) 0/1127 (0)
Initial rhythm
 VF/VT, n (%) 1071/1646 (65.0) 318/503 (63.2) 753/1143 (65.8) 0.297
 PEA/asystole, n (%) 575/1646 (34.9) 185/503 (36.7) 390/,1143 (34.1) 0.297
Presumed cardiac origin, n (%) 1358/1648 (82.4) 403/505 (79.8) 955/1143 (83.5) 0.065
Presumed cause of cardiac arrest
 Acute coronary syndrome, n (%) 924/1639 (56.3) 274/502 (54.5) 650/1137 (57.1) 0.330
 Arrhythmia, n (%) 232/1639 (14.1) 62/502 (12.3) 170/1137 (14.9) 0.164
 Pulmonary embolism, n (%) 52/1639 (3.1) 20/502 (3.9) 32/1137 (2.8) 0.213
 Aortic dissection, n (%) 92/1639 (5.6) 18/502 (3.5) 74/1137 (6.5) 0.018
 Primary cerebral disorders n (%) 50/1639 (3.0) 32/502 (6.3) 18/1137 (1.5)  < 0.001
 Other, n (%) 289/1639 (17.6) 96/502 (19.1) 193/1137 (16.9) 0.031
Witnessed collapse, n (%) 1295/1652 (78.3) 407/506 (80.4) 888/1146 (77.4) 0.180
Bystander CPR, n (%) 949/1633 (58.1) 290/500 (58.0) 659/,1133 (58.1) 0.951
ECPR
Time interval (min), median [IQR]
 EMS arrival-ECMO pump on 41 [28–49] 41 [27–48] 41 [28–49] 0.242
IABP use, n (%) 1018/1656 (61.4) 300/510 (58.8) 718/1146 (62.6) 0.139
 ECMO-related complications, n (%) 410/1660 (24.7) 125/510 (24.5) 285/1150 (24.7) 0.905
 Procedure‑related complications, n (%) 256/1653 (15.4) 75/505 (14.8) 206/1148 (15.7) 0.653
 Brain ischemia, n (%) 6/1660 (0.3) 2/510 (0.3) 4/1150 (0.3) 0.890
 Mesenteric ischemia, n (%) 9/1654 (0.5) 3/505 (0.5) 6/1149 (0.5) 0.855
 Cerebral hemorrhage, n (%) 16/1644 (0.9) 8/510 (1.5) 8/1150 (0.7) 0.093
 Gastrointestinal bleeding, n (%) 35/1654 (2.1) 19/508 (3.7) 16/1146 (1.4) 0.002
 Other hemorrhagic complication, n (%) 101/1654 (6.1) 28/508 (5.5) 73/1146 (6.3) 0.829
 ECMO mechanical complication, n (%) 27/1628 (1.6) 11/500 (2.2) 16/1128 (1.4) 0.255
ICU data and treatments
Blood gas pH (ICU admission), median [IQR] 7.30 [7.20–7.39] 7.30 [7.19–7.40] 7.30 [7.20–7.38] 0.848
Serum lactate (mmol/L), median [IQR] 7.8 [5.3–11.6] 8.4 [5.7–12.0] 7.6 [5.0–11.3] 0.008
SOFA score, median [IQR] 12 [8–13] 12 [8–13] 12 [9–13] 0.460
Pupil diameter ≥ 4 mm on ICU admission, n (%) 398/1233 (32.2) 138/420 (32.8) 260/813 (31.9) 0.755
Pupil diameter ≥ 6 mm on ICU admission, n (%) 132/1233 (10.7) 57/420 (13.5) 75/813 (9.2) 0.019
Sepsis, n (%) 135/1368 (9.8) 43/457 (9.4) 92/911 (10.1) 0.687
Septic shock, n (%) 87/1363 (6.3) 35/457 (7.6) 52/906 (5.7) 0.171
Acute renal failure, n (%) 553/1349 (40.9) 218/455 (47.9) 335/894 (37.4)  < 0.001
Ventilator-associated pneumonia, n (%) 162/1342 (12.0) 45/449 (10.0) 117/893 (13.1) 0.102
Vasopressor use, n (%) 629/1362 (46.1) 192/454 (42.2) 437/908 (48.1) 0.042
Renal replacement therapy, n (%) 236/1357 (17.3) 69/453 (15.2) 167/904 (18.4) 0.137
Tracheostomy, n (%) 245/1642 (14.9) 52/505 (10.3) 193/1137 (16.9)  < 0.001
Temperature management, n (%)
 32 °C-below 36 °C 828/1112 (74.4) 237/328 (72.2) 591/784 (75.3) 0.276
 36 °C or higher 284/1112 (25.5) 91/328 (27.7) 193/784 (24.6) 0.276
 Temperature management canceled, n (%) 324/1095 (29.5) 106/322 (32.9) 218/773 (28.2) 0.119

CPR Cardiopulmonary resuscitation, ECMO Extracorporeal membrane oxygenation, ECPR Extracorporeal cardiopulmonary resuscitation, EMS Emergency medical service, IABP Intra-aortic balloon pump, ICU Intensive care unit, IQR Interquartile range, SOFA Sequential organ failure assessment, OHCA Out-of-hospital cardiac arrest, PEA Pulseless electrical activity, PS Performance status, VF Ventricular fibrillation, VT Ventricular tachycardia, WLST Withholding/withdrawal of life-sustaining therapy